DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 7000 participants.

Also called NCT07795398

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 7,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07795398
  • EU CT 2026-525442-30-00
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07795398. Randomized; no masking; primary purpose treatment. Start 2026-09-30 (actual); primary completion 2029-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease
Acronym
DAN-RELEASE
Condition
Ischemic Heart Disease
Condition
Ischemic Heart Disease Chronic
Condition
Chronic Coronary Syndrome
Condition
Aspirin
Condition
Aspirin Causing Adverse Effects in Therapeutic Use
Intervention (Drug)
Continuation of daily low-dose Aspirin
Intervention (Drug)
Discontinuation of daily low-dose Aspirin
Lead sponsor
Odense University Hospital (class: other)
Collaborator
University Hospital Bispebjerg and Frederiksberg (class: other)

Record details

Record id
cardio:ct-nct07795398
Content hash
61dfbb40fa3a7162e6b430c0f6f5d5fe45b23e6285e540e7513a4028cf767bb6